$39.2 Million is the total value of Healthcare Value Capital, LLC's 19 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 26.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GSK | GLAXOSMITHKLINE PLCsponsored adr | $4,079,000 | +7.7% | 100,000 | 0.0% | 10.41% | +63.4% | |
GILD | GILEAD SCIENCES INC | $3,847,000 | +2.9% | 50,000 | 0.0% | 9.82% | +56.2% | |
SPXU | Buy | PROSHARES TRultrapro short s | $2,950,000 | -18.5% | 250,000 | +66.7% | 7.53% | +23.8% |
MNLO | Buy | MENLO THERAPEUTICS INC | $2,941,000 | +29.1% | 1,700,000 | +100.0% | 7.51% | +96.0% |
TYME | TYME TECHNOLOGIES INC | $2,893,000 | +20.9% | 2,175,000 | 0.0% | 7.39% | +83.5% | |
CAH | Sell | CARDINAL HEALTH INC | $2,610,000 | -27.4% | 50,000 | -33.3% | 6.66% | +10.2% |
ABBV | Sell | ABBVIE INC | $2,455,000 | -35.6% | 25,000 | -50.0% | 6.27% | -2.2% |
SPXU | Buy | PROSHARES TRcall | $2,360,000 | +30.5% | 200,000 | +166.7% | 6.02% | +98.0% |
WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $2,120,000 | +85.3% | 50,000 | +100.0% | 5.41% | +181.3% |
JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $2,096,000 | -29.9% | 19,000 | -36.7% | 5.35% | +6.3% |
CLVS | CLOVIS ONCOLOGY INC | $1,688,000 | +6.2% | 250,000 | 0.0% | 4.31% | +61.2% | |
CVS | CVS HEALTH CORP | $1,624,000 | +9.5% | 25,000 | 0.0% | 4.15% | +66.2% | |
MCK | Sell | MCKESSON CORP | $1,534,000 | -54.6% | 10,000 | -60.0% | 3.92% | -31.1% |
ABC | Sell | AMERISOURCEBERGEN CORP | $1,512,000 | -43.1% | 15,000 | -50.0% | 3.86% | -13.6% |
ATRS | ANTARES PHARMA INC | $1,375,000 | +16.5% | 500,000 | 0.0% | 3.51% | +76.9% | |
GNLN | Buy | GREENLANE HLDGS INCcl a | $995,000 | +157.1% | 250,000 | +11.1% | 2.54% | +290.2% |
VKTX | VIKING THERAPEUTICS INCcall | $721,000 | +54.1% | 100,000 | 0.0% | 1.84% | +133.9% | |
AMRN | Sell | AMARIN CORP PLCcall | $692,000 | -13.5% | 100,000 | -50.0% | 1.77% | +31.3% |
CLVS | CLOVIS ONCOLOGY INCcall | $675,000 | +6.1% | 100,000 | 0.0% | 1.72% | +61.0% | |
ADMS | Exit | ADAMAS PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.97% | – |
BIS | Exit | PROSHARES TRcall | $0 | – | -75,000 | -100.0% | -1.78% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -4.53% | – |
SPXL | Exit | DIREXION SHS ETF TRcall | $0 | – | -120,000 | -100.0% | -5.26% | – |
LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -25,000 | -100.0% | -5.32% | – |
AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -75,000 | -100.0% | -5.64% | – |
GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -50,000 | -100.0% | -6.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
PFIZER INC | 19 | Q3 2021 | 17.9% |
TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-15 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.